Skip to main content
Michael Ober, MD, Ophthalmology, Southfield, MI, Straith Hospital for Special Surgery

MichaelDOberMD

Ophthalmology Southfield, MI

Retinal Disease

Vitreoretinal Surgeon at Retina Consultants of Michigan Associate Professor of Ophthalmology Oakland University William Beaumont School of Medicine Teaching Faculty Henry Ford Hospital Chief of Staff, Straith Hospital for Special Surgery

Dr. Ober is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Ober's full profile

Already have an account?

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Fellowship, Surgical Retina and Vitreous, 2003 - 2005
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Ophthalmology, 1999 - 2003
  • Beaumont Health (Royal Oak)
    Beaumont Health (Royal Oak)Internship, Transitional Year, 1999 - 2000
  • Wayne State University School of Medicine
    Wayne State University School of MedicineClass of 1999, MD
  • Cornell University
    Cornell UniversityBA, Chemistry, 1991 - 1995

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2000 - Present
  • CA State Medical License
    CA State Medical License 2003 - 2025
  • MI State Medical License
    MI State Medical License 1999 - 2024
  • American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

  • Fellow (FAAO) American Academy of Ophthalmology
  • Fellow (FACS) American College of Surgeons

Publications & Presentations

PubMed

Press Mentions

  • Diagnosis and Management of Pathologic Myopia
    Diagnosis and Management of Pathologic MyopiaNovember 1st, 2019
  • SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and More
    SUBSPECIALTY NEWS: Results for Combination Therapy for DME, FDA Asks for Information on Xipere, Depo-Medrol Retinal Toxicity, and MoreOctober 1st, 2019

Professional Memberships

Hospital Affiliations